ViiV Healthcare Company et al v. Aurobindo Pharma Ltd. et al
| ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No.3) Limited |
| Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. |
| Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. |
| Shionogi & Co., Ltd., ViiV Healthcare Company and ViiV Healthcare UK (No.3) Limited |
| 1:2025cv01331 |
| October 30, 2025 |
| U.S. District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 23, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #20 STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to May 22, 2026 filed by ViiV Healthcare UK (No.3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. Signed by Judge Gregory B. Williams on 4/23/2026. (lnb)
|
| Filing 20 STIPULATION TO EXTEND TIME the deadline for the Parties to submit a Proposed Scheduling Order to May 22, 2026 - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Joyce, Alexandra) |
| Filing 19 NOTICE of Withdrawal of Daniel J. Ritterbeck by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth) |
| Remark --Terminated Attorney Daniel J. Ritterbeck due to D.I. 19 (lnb) |
|
SO ORDERED, re #18 STIPULATION TO EXTEND TIME for the Parties to submit a Proposed Scheduling Order to April 22, 2026 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Gregory B. Williams on 3/24/2026. (jaa)
|
| Filing 18 STIPULATION TO EXTEND TIME for the Parties to submit a Proposed Scheduling Order to April 22, 2026 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
|
SO ORDERED, re #17 STIPULATION TO EXTEND TIME for the parties to file a Proposed Scheduling Order to March 23, 2026 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Gregory B. Williams on 2/18/2026. (lnb)
|
| Filing 17 STIPULATION TO EXTEND TIME for the parties to file a Proposed Scheduling Order to March 23, 2026 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Filing 16 ANSWER to #13 Answer to Complaint, Counterclaim by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited.(Silver, Daniel) |
|
Filing 15
ORAL ORDER: IT IS HEREBY ORDERED that, by no later than February 20, 2026, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. ORDERED by Judge Gregory B. Williams on 1/20/2026. (lnb)
|
| Pro Hac Vice Attorney Daniel J. Ritterbeck, Dennies Varughese & Ryan N. Kaiser for Aurobindo Pharma Ltd. & Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Gregory B. Williams on 1/2/26. (jaa)
|
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Filing 13 ANSWER to #1 Complaint, Affirmative Defenses and, COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd..(Hitch, Cortlan) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Ryan N. Kaiser, Daniel J. Ritterbeck, and Dennies Varughese. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese )( Payment of $ 150, receipt number ADEDC-4866398).(Hitch, Cortlan) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Ryan N. Kaiser, Attorney Daniel J. Ritterbeck, and Attorney Dennies Varughese - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
|
SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Aurobindo to Answer, Move or Otherwise respond to the Complaint to December 29, 2025 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Set/Reset Answer Deadlines: All Defendants. Signed by Judge Gregory B. Williams on 12/12/2025. (lnb)
|
| Filing 10 STIPULATION TO EXTEND TIME for Aurobindo to Answer, Move or Otherwise respond to the Complaint to December 29, 2025 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Filing 9 DECLARATION of Service for Aurobindo Pharma Ltd. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) |
| Filing 8 SUMMONS Returned Executed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited.Aurobindo Pharma USA, Inc. served on 11/24/2025, answer due 12/15/2025. (Silver, Daniel) |
| Filing 7 NOTICE of Supplemental Rule 7.1 Disclosure Statement for Plaintiffs ViiV Healthcare Company and ViiV Healthcare UK (No. 3) Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited (Silver, Daniel) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb) |
| Filing 6 Summons Issued as to Aurobindo Pharma Ltd. on 10/31/2025; Aurobindo Pharma USA, Inc. on 10/31/2025. (Attachments: #1 Summons Issued)(oam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent ViiV Healthcare Company, Corporate Parent Viiv Healthcare UK Limited, Other Affiliate GSK plc, Other Affiliate GlaxoSmithKline Mercury Limited, Other Affiliate PHIVCO Luxembourg Sarl, Other Affiliate PHIVCO Corp, Other Affiliate Shionogi B.V., Other Affiliate ViiV Healthcare Limited. for ViiV Healthcare UK (No.3) Limited; Corporate Parent ViiV Healthcare Limited, Other Affiliate GSK plc, Other Affiliate GlaxoSmithKline Mercury Limited, Other Affiliate PHIVCO Luxembourg Sarl, Other Affiliate PHIVCO Corp, Other Affiliate Shionogi B.V., Other Affiliate ViiV Healthcare Limited. for ViiV Healthcare Company filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited.No Parents or Affiliates Listed for Shionogi & Co., Ltd. filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No.3) Limited. (Attachments: #1 7.1 Disclosure)(oam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (oam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/18/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/18/2028. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. ( Filing fee $ 405, receipt number ADEDC-4826292.) - filed by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No.3) Limited. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
